Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions

This study has been completed.
Sponsor:
Information provided by:
Ranbaxy Inc.
ClinicalTrials.gov Identifier:
NCT00779376
First received: October 23, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2005
  Primary Completion Date: March 2005 (Final data collection date for primary outcome measure)